Home » Stocks » AXIM

AXIM Biotechnologies, Inc. (AXIM)

Stock Price: $0.4300 USD 0.0000 (0.00%)
Updated Jan 25, 2021 3:59 PM EST - Market closed
Market Cap 53.83M
Revenue (ttm) 293,462
Net Income (ttm) -5.45M
Shares Out 123.50M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 25
Last Price $0.4300
Previous Close $0.4300
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.4300
Day's Range 0.4200 - 0.4799
Day's Volume 202,986
52-Week Range 0.1 - 1.27

News

GlobeNewsWire - 2 weeks ago

SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- AXIM ®  Biotechnologies, Inc .  (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting o...

About AXIM

AXIM Biotechnologies is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). The company's NeuCovix is the rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. It is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The company was formerly known as Axim International Inc. ... [Read more...]

Industry
Biotechnology
Founded
2010
CEO
John W. Huemoeller II
Employees
4
Stock Exchange
OTCMKTS
Ticker Symbol
AXIM
Full Company Profile

Financial Performance

In 2019, AXIM's revenue was $799,483, an increase of 308.70% compared to the previous year's $195,614. Losses were -$6.45 million, -4.55% less than in 2018.

Financial Statements